Gary Speier is a registered patent attorney and shareholder with Schwegman, Lundberg & Woessner. His practice includes many facets of patent law, including patent preparation, prosecution, due diligence, opinion drafting, client counseling, clearance reviews and technology licensing and transfer agreements. Gary also counsels clients on legal issues relating to chemical and pharmaceutical patents, including patent enforcement, validity and infringement, licensing, collaborations, due diligence and business development. His experience in transactional matters for chemical and pharmaceutical clients includes IP due diligence. Gary 's experience with clearance reviews and legal opinions has included a significant amount of work related to Paragraph IV certifications for Abbreviated New Drug Applications (ANDA) under the Hatch-Waxman Act.
Gary represents clients in diverse areas of technology, and has obtained patents in the areas of chemistry and pharmaceuticals. Specific areas of patent technology experience include small molecules, macrocycles, biologicals, polymers, peptides, peptidomimetics, oligonucleotides, carbohydrates, medical treatments, industrial chemicals, medical devices, cosmetics, drug delivery systems, nutraceuticals, natural products, agricultural products, process engineering, nanoparticles and food chemistry. Additional specific areas of patent technology experience include the Green technologies such as fuel cells, batteries, biofuels, biomass conversions, water purification, plastics recycling, bio-friendly plastic alternatives, as well as solar, wind and geothermal energies. Please see "Representative Patents."
